Lacey, WA – October 14, 2004 - Aloecorp, the world’s leading vertically integrated supplier of bioactive Aloe vera raw materials, reports that Aloe vera is one of the few natural ingredients proven in human clinical trials to show promising results for addressing health concerns related to diabetes - without the side effects often associated with drugs.
According to 2002 statistics from the American Diabetes Association (ADA) diabetes affects nearly 18.2 million Americans, or 6.3% of the population, and in the year 2000 was cited as the sixth leading cause of death. Diabetes involves a deficiency or absence of the hormone insulin, the main hormone responsible for the control of sugar in the blood, resulting in an unhealthy increase in blood sugar levels, along with an increase in oxidative stress, lower levels of free radical-fighting antioxidants such as vitamins C and E, and an increased risk of heart disease, stroke and high blood pressure.
According to Ken Jones, Aloecorp’s Director of Research and Development, “Various studies and human clinical trials have shown that Aloe vera has had a significant effect on health concerns related to Type 2 diabetes, such as the regulation of blood sugar, triglyceride and serum cholesterol levels, as well as improvements in lipid profiles and suppressed free radical-induced oxidative damage.” Jones added that a large number of human clinical trial participants were able to decrease or discontinue the medications they were previously taking to regulate their blood sugar levels, hypertension and angina.
John Rhees, Aloecorp’s President and Chief Executive Officer, further commented, “Thanks to scientific advancements and sound results in the study of aloe for addressing diabetes, people experiencing this disease now have a natural and safe option for supporting improved health. I am thrilled that the Aloe Industry can assist those involved in such a huge and growing public health concern.”
Those afflicted with Type 1 diabetes must take insulin because their bodies do not produce enough of it; those suffering from Type 2 diabetes may control their condition through healthy diet and exercise. In contrast to people suffering from Type 1 diabetes, Type 2 diabetes can be controlled in some cases through diet and exercise, while others do require medication to control their blood sugar. Studies have shown that regular supplementation with Aloe vera can positively affect the health of Type 2 diabetics.
To learn more about the positive benefits of Aloe vera and diabetes, or to obtain a full copy of “The Antidiabetic Activity of Aloe vera” written by Ken Jones, contact Susan Westfall at Westfall Communications.
# # #
Aloecorp (www.aloecorp.com) and sister company Unigen Pharmaceuticals, Inc. (www.unigenpharma.com) are subsidiaries of Univera, Inc. Unigen and Aloecorp each focus on identifying and studying the unique ingredients of medicinal botanicals (Aloecorp’s focus is on Aloe vera) and then formulating proprietary raw materials for use in cosmeceutical, nutraceutical and pharmaceutical products.
Aloecorp is a multinational company providing research-proven, bioactive Aloe vera ingredients to world markets. Aloecorp’s corporate philosophy is to “bring the best of nature to mankind,” and does so with its bioactive, standardized Aloe vera that guarantees 10% polysaccharides by weight, and is clinically proven to enhance the activity of Native Aloe gel. Since its inception in 1988, Aloecorp has been the world’s leading vertically integrated supplier of raw Aloe vera materials. All of Aloecorp’s raw Aloe vera materials have been scientifically tested for biological activity, certified pure by the International Aloe Science Council, and clinically supported in published, peer-reviewed studies. Aloecorp provides raw Aloe vera materials to finished goods manufacturers in the nutritional and dietary supplement, functional food, cosmeceutical, personal care and pharmaceutical industries. Aloecorp, ACTIValoe™, and all associated logos are registered trademarks of Aloecorp in the United States and other countries. Unigen Pharmaceuticals, Inc. has granted Aloecorp an exclusive licensing agreement to use its patented processes to manufacture ACTIValoe™.
Susan Westfall, President
Westfall Communications, Inc.